40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
10.98%
Revenue growth 50-75% of CRK's 19.30%. Martin Whitman would scrutinize if slower growth is temporary.
-1.84%
Cost reduction while CRK shows 30.96% growth. Joel Greenblatt would examine competitive advantage.
25.49%
Gross profit growth exceeding 1.5x CRK's 15.16%. David Dodd would verify competitive advantages.
13.07%
Margin expansion while CRK shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.11%
Other expenses growth less than half of CRK's 5.38%. David Dodd would verify if advantage is sustainable.
1.91%
Similar operating expenses growth to CRK's 2.28%. Walter Schloss would investigate norms.
-0.80%
Total costs reduction while CRK shows 12.75% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
6.38%
D&A growth 1.1-1.25x CRK's 5.36%. Bill Ackman would demand investment justification.
29.29%
EBITDA growth exceeding 1.5x CRK's 18.18%. David Dodd would verify competitive advantages.
-6.45%
Both companies show margin pressure. Martin Whitman would check industry conditions.
44.01%
Operating income growth 1.25-1.5x CRK's 35.83%. Bruce Berkowitz would examine sustainability.
29.76%
Operating margin growth exceeding 1.5x CRK's 13.86%. David Dodd would verify competitive advantages.
84.18%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
165.05%
Pre-tax income growth exceeding 1.5x CRK's 39.56%. David Dodd would verify competitive advantages.
138.82%
Pre-tax margin growth exceeding 1.5x CRK's 16.99%. David Dodd would verify competitive advantages.
96.50%
Tax expense growth above 1.5x CRK's 31.95%. Michael Burry would check for concerning trends.
190.57%
Net income growth exceeding 1.5x CRK's 45.06%. David Dodd would verify competitive advantages.
161.81%
Net margin growth exceeding 1.5x CRK's 21.60%. David Dodd would verify competitive advantages.
193.54%
EPS growth exceeding 1.5x CRK's 44.83%. David Dodd would verify competitive advantages.
195.00%
Diluted EPS growth exceeding 1.5x CRK's 46.43%. David Dodd would verify competitive advantages.
-8.98%
Share count reduction while CRK shows 0.02% change. Joel Greenblatt would examine strategy.
-9.50%
Diluted share reduction while CRK shows 0.28% change. Joel Greenblatt would examine strategy.